Integrative analysis reveals a molecular stratification of systemic autoimmune diseases

…, I Diaz Quintero, A EscuderoContreras… - Arthritis & …, 2021 - Wiley Online Library
Objective Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes
early diagnosis and effective treatment, issues that may be addressed if patients could be …

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

…, E Collantes-Estevez, A Escudero-Contreras… - Translational …, 2017 - Elsevier
Tocilizumab (TCZ) is an effective treatment for rheumatoid arthritis (RA). However, the changes
that occurred after TCZ therapy on endothelial dysfunction, monocyte activity, NETosis, …

Óptima utilización del metotrexato

RO Castro, AE Contreras, JC Gutiérrez… - Seminarios de la …, 2013 - Elsevier
El metotrexato es considerado hoy en día como el fármaco antirreumático modificador de la
enfermedad de primera elección en el tratamiento de la artritis reumatoide, en razón a su …

Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients

…, A Escudero-Contreras… - Human molecular …, 2018 - academic.oup.com
Ankylosing spondylitis (AS) remains difficult to diagnose before irreversible damage to
sacroiliac joint is noticeable. Circulating microRNAs have demonstrated to serve as diagnostic …

Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation

…, N Barbarroja, A Escudero-Contreras… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Systemic lupus erythematosus (SLE) is associated to boosted atherosclerosis
development and a higher cardiovascular disease risk. This study aimed to delineate the role of …

Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage

…, R Ortega-Castro, A Escudero-Contreras… - Clinical …, 2018 - Springer
To evaluate quality of life (QoL) in patients with axial spondyloarthritis (axSpA) and its association
with disease activity, functionality, structural damage, and spinal mobility, using patient-…

[HTML][HTML] Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic …

…, JL Garrido-Castro, A Escudero-Contreras… - Joint Bone …, 2021 - ncbi.nlm.nih.gov
The Spanish lockdown during the COVID-19 pandemic has been one of the strictest among
European countries since neither short walks nor individual sports were allowed for 7 weeks…

Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

C Perez‐Sanchez, A EscuderoContreras… - Arthritis & …, 2023 - Wiley Online Library
Escudero-Contreras were dual first authors and contributed equally to this work. Dr. …
Escudero-Contreras were dual first authors and contributed equally to this work. Dr. Collantes-…

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

…, J Calvo, RO Castro, A Escudero-Contreras… - Annals of the …, 2022 - ard.bmj.com
Objectives To characterise splicing machinery (SM) alterations in leucocytes of patients with
rheumatoid arthritis (RA), and to assess its influence on their clinical profile and therapeutic …

[HTML][HTML] Effects of biological therapies on molecular features of rheumatoid arthritis

…, E Collantes-Estevez, A Escudero-Contreras… - International Journal of …, 2020 - mdpi.com
Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disease primarily
affecting the joints, and closely related to specific autoantibodies that mostly target modified self-…